These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38464913)

  • 1. Resolution of Wing-Beating Tremor and Magnetic Resonance Imaging Lesions in Wilson's Disease Following Penicillamine.
    Brum IV; Parmera JB; Otani RTV; Prates IR; Lucato LT; Cury RG; Barbosa ER
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():9. PubMed ID: 38464913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatolenticular degeneration, Wilson's disease. A characteristics case with remission under penicillamine therapy].
    Hansen J; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1306-9. PubMed ID: 5824791
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson's disease.
    Chu CC; Huang CC; Chu NS
    Nephron; 1996; 73(3):477-9. PubMed ID: 8832611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological features and outcomes of Wilson's disease: a single-center experience.
    Samanci B; Sahin E; Bilgic B; Tufekcioglu Z; Gurvit H; Emre M; Demir K; Hanagasi HA
    Neurol Sci; 2021 Sep; 42(9):3829-3834. PubMed ID: 33474589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Challenging Case of Wilson's Disease.
    João Soares R; Monteiro N; Machado J; Silva Marques J; Nunes A
    Cureus; 2023 Jul; 15(7):e42655. PubMed ID: 37644923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
    Huang CC; Chu NS
    Eur Neurol; 1998; 39(1):32-7. PubMed ID: 9476721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Spectrum, Radiological Correlation and Outcome of Movement Disorders in Wilson's Disease.
    Mahale RR; Stezin A; Prasad S; Kamble N; Holla VV; Netravathi M; Yadav R; Pal PK
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():37. PubMed ID: 37840995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.
    Huang CC; Chu NS
    J Formos Med Assoc; 1992 Jun; 91(6):627-9. PubMed ID: 1358351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Wilson's disease combined with intracranial lipoma and dysplasia of the corpus callosum with review of the literature.
    Zhang L; Zhu L; Ci C; Ai W; Wang Y; Wang X
    BMC Neurol; 2024 Jan; 24(1):44. PubMed ID: 38273263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Capsular Hyperintensities in Wilson's Disease Presenting with Refractory Status Epilepticus.
    Ruchika T; Madhukar M; Abhishek KG
    Neurol India; 2022; 70(6):2446-2448. PubMed ID: 36537433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
    Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
    J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Wilson's disease: penicillamine or triene?
    Kiechl SG; Willeit J; Aichner F; Felber S
    Acta Neurol Scand; 1992 Feb; 85(2):154-7. PubMed ID: 1574992
    [No Abstract]   [Full Text] [Related]  

  • 14. Unilateral rubral tremors in Wilson's disease treated with dimercaprol.
    Chakor RT; Bharote H; Eklare N; Tamboli K
    Ann Indian Acad Neurol; 2015; 18(1):115-6. PubMed ID: 25745328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-occurring Wilson's disease and non-penicillamine-induced systematic lupus erythematosus: a case report and literature review.
    Shi W; Huang X; Zhang S; Jiao Y
    Clin Rheumatol; 2021 Jun; 40(6):2485-2490. PubMed ID: 33057918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance zinc therapy after initial penicillamine chelation to treat symptomatic hepatic Wilson's disease in resource constrained setting.
    Gupta P; Choksi M; Goel A; Zachariah U; Sajith KG; Ramachandran J; Chandy G; Kurian G; Rebekah G; Eapen CE
    Indian J Gastroenterol; 2018 Jan; 37(1):31-38. PubMed ID: 29457214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of trientine therapy in Wilson's disease with neurological symptoms].
    Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
    No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment and posttreatment positron emission tomographic scan imaging in a 20-year-old patient with Wilson's disease.
    Cordato DJ; Fulham MJ; Yiannikas C
    Mov Disord; 1998 Jan; 13(1):162-6. PubMed ID: 9452344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible magnetic resonance imaging lesions in Wilson's disease: clinical-anatomical correlation.
    Takahashi W; Yoshii F; Shinohara Y
    J Neuroimaging; 1996 Oct; 6(4):246-8. PubMed ID: 8903079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.